| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 4.7e-05 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 8.7e-06 | 1 |